Literature DB >> 6124036

Schizophrenia: dopamine beta-hydroxylase activity and treatment response.

D E Sternberg, D P VanKammen, P Lerner, W E Bunney.   

Abstract

Cerebrospinal fluid levels of dopamine beta-hydroxylase, found to be relatively constant over time in individual patients, were significantly lower in schizophrenic patients who became nonpsychotic during neuroleptic treatment than in those who remained psychotic. Dopamine beta-hydroxylase activity may delineate a subgroup of patients who have a dopamine-sensitive brain disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124036     DOI: 10.1126/science.6124036

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Characterization of SNPs in the dopamine-β-hydroxylase gene providing new insights into its structure-function relationship.

Authors:  Toyanji Joseph Punchaichira; Sanjay Kumar Dey; Anirban Mukhopadhyay; Suman Kundu; B K Thelma
Journal:  Neurogenetics       Date:  2017-07-13       Impact factor: 2.660

2.  Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects.

Authors:  Toyanji J Punchaichira; Anirban Mukhopadhyay; Prachi Kukshal; Triptish Bhatia; Smita N Deshpande; B K Thelma
Journal:  J Psychopharmacol       Date:  2020-01-08       Impact factor: 4.153

Review 3.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

4.  Determination of Dopamine-β-hydroxylase Activity in Human Serum Using UHPLC-PDA Detection.

Authors:  Toyanji Joseph Punchaichira; Smita Neelkanth Deshpande; B K Thelma
Journal:  Neurochem Res       Date:  2018-10-24       Impact factor: 3.996

5.  Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatment.

Authors:  K Mncube; B H Harvey
Journal:  IBRO Neurosci Rep       Date:  2022-09-05

6.  Physiogenomic analysis of localized FMRI brain activity in schizophrenia.

Authors:  Andreas Windemuth; Vince D Calhoun; Godfrey D Pearlson; Mohan Kocherla; Kanchana Jagannathan; Gualberto Ruaño
Journal:  Ann Biomed Eng       Date:  2008-03-11       Impact factor: 3.934

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.